Notice: Trading of Traws Pharma halted at 09:31 AM EST due to "LULD pause". Traws Pharma (TRAW) News Today $4.50 +0.01 (+0.22%) (As of 02:50 PM ET) Add Compare Share Share Headlines Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesOptions ChainSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period Traws Pharma Reports Q3 Financials and Updates on Clinical AdvancesNovember 17, 2024 | msn.comTraws Pharma Faces Uncertain Future Amid Complex Onconova MergerNovember 16, 2024 | tipranks.comTraws Pharma Reports Promising Antiviral Drug ProgressNovember 16, 2024 | markets.businessinsider.comTraws Pharma Faces Uncertain Future Amid Complex Onconova MergerNovember 16, 2024 | markets.businessinsider.comTraws Pharma Provides Business Update and Reports Q3 2024 Financial ResultsNovember 14, 2024 | globenewswire.comTraws Pharma, Inc. (NASDAQ:TRAW) Short Interest Up 652.9% in SeptemberTraws Pharma, Inc. (NASDAQ:TRAW - Get Free Report) was the recipient of a significant growth in short interest in September. As of September 30th, there was short interest totalling 12,800 shares, a growth of 652.9% from the September 15th total of 1,700 shares. Based on an average daily volume of 7,800 shares, the short-interest ratio is currently 1.6 days. Approximately 0.6% of the shares of the company are short sold.October 10, 2024 | marketbeat.comExpert Systems Celebrates Milestone in Clinical Development of Tivoxavir Marboxil, Potential One-Time Influenza TreatmentOctober 10, 2024 | tmcnet.comTraws Pharma Reports Positive Phase 1 Results for Influenza Therapy Tivoxavir MarboxilOctober 10, 2024 | msn.comTraws Pharma Inc (TRAW) Q2 2024 Earnings Call Highlights: Navigating Financial Challenges Amid ...October 10, 2024 | finance.yahoo.comTraws Pharma Reports Positive Topline Phase 1 Data For Flu Candidate, Tivoxavir Marboxil; Stock UpOctober 8, 2024 | markets.businessinsider.comTraws Pharma Announces Positive Topline Phase 1 Data for Flu Candidate, Tivoxavir MarboxilOctober 8, 2024 | globenewswire.comPromising Phase 1 Results for Traws Pharma’s COVID Treatment CandidateOctober 2, 2024 | msn.comWhy Traws Pharma Is Rising In Pre-market?October 1, 2024 | markets.businessinsider.comTraws Pharma Announces Positive Topline Phase 1 Results for COVID Candidate, Ratutrelvir, an Oral Mpro InhibitorSeptember 30, 2024 | globenewswire.comTraws Pharma Inc (0T20.F)September 24, 2024 | au.finance.yahoo.comOrbimed Advisors LLC Reduces Stake in Traws Pharma IncSeptember 24, 2024 | finance.yahoo.comTraws Pharma Welcomes Luba Greenwood Amid Strategic Board ChangesSeptember 21, 2024 | msn.comTraws Pharma, Inc. Appoints Luba Greenwood to Board of DirectorsSeptember 20, 2024 | globenewswire.comTraws Pharma Announces Key Approvals and Reverse Stock Split at 2024 Special MeetingSeptember 20, 2024 | msn.comTRAWS PHARMA INC. DL-,01 (0T2.DU)September 19, 2024 | au.finance.yahoo.comMantle Cell Lymphoma Clinical Trial Pipeline Insights Featuring 20+ Companies | DelveInsightSeptember 19, 2024 | finance.yahoo.comDelveInsight Business Research, LLP: Mantle Cell Lymphoma Clinical Trial Pipeline Insights Featuring 20+ Companies | DelveInsightSeptember 19, 2024 | finanznachrichten.deTraws Pharma, Inc. Announces Special Shareholders Meeting ResultsSeptember 17, 2024 | globenewswire.comTraws Pharma, Inc. (TRAW) Corporate Update Call TranscriptAugust 20, 2024 | seekingalpha.comTraws Pharma, Inc.: Traws Pharma Reports Q2 2024 Financial Results, Provides Recent Business HighlightsAugust 15, 2024 | finanznachrichten.deTraws Pharma Reports Q2 2024 Financial Results, Provides Recent Business HighlightsAugust 15, 2024 | finance.yahoo.comTraws Pharma Reports Q2 2024 Financial Results, Provides Recent Business HighlightsAugust 15, 2024 | globenewswire.comTraws Pharma Inc TRAWAugust 9, 2024 | morningstar.comTraws Pharma Inc (TRAW)July 25, 2024 | uk.investing.com0T2.SG,0P0000ZC8L,0 (0T2.SG)July 19, 2024 | finance.yahoo.com Get Traws Pharma News Delivered to You Automatically Sign up to receive the latest news and ratings for TRAW and its competitors with MarketBeat's FREE daily newsletter. Email Address 2025 AI Stock Picks: 2 Hidden Gems Under $10/Share (Ad)The AI sector continues to make waves as we move into 2025, and now is a prime opportunity to get involved—without stretching your budget! We’ve just uncovered 2 promising AI stocks trading for under $10/share, and they’re positioned for impressive growth in the coming months. 👉[Click here to get your FREE report delivered instantly!] TRAW Media Mentions By Week TRAW Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. TRAW News Sentiment▼-0.050.47▲Average Medical News Sentiment TRAW News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. TRAW Articles This Week▼61▲TRAW Articles Average Week Get Traws Pharma News Delivered to You Automatically Sign up to receive the latest news and ratings for TRAW and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Lantern Pharma News Today Acasti Pharma News Today ProMIS Neurosciences News Today Citius Pharmaceuticals News Today Ocuphire Pharma News Today KALA BIO News Today RenovoRx News Today BioVie News Today HCW Biologics News Today Hookipa Pharma News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:TRAW) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredElon knows the truth, which is why they want him silencedElon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to h...Porter & Company | Sponsored24/7 Automated Profits in CryptoThe 4th quarter of 2024 is shaping up to be one of the most explosive periods for crypto in recent memory. But...Crypto Swap Profits | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Traws Pharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Traws Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
